Podiatric Foot Surgeon Mr. Stuart Metcalfe Recognized as First HyProCure Center of Excellence in UK

MACOMB, Mich. - July 5, 2016 - PRLog -- Over the years, Mr. Stuart Metcalfe, a Consultant Podiatric Surgeon, practicing in a demanding subspecialty covering all aspects of medical and surgical treatments of the foot, has performed thousands of foot surgeries and published over 25 peer-reviewed articles in medical journals. In 2009, Mr. Metcalfe's desire to expand his knowledge and training led him to incorporating the HyProCure® Sinus Tarsi Stent into his practice. Providing patients, young and old, minimally invasive treatments for flexible flatfeet, he integrated HyProCure and performed a significant number of procedures. This led GraMedica to certify Mr. Metcalfe as a Master Surgeon, an expert. Today, GraMedica is excited to announce and recognize Mr. Metcalfe as the first HyProCure® International Center of Excellence (ICOE) in the United Kingdom.

As a Consultant Podiatric Surgeon, Mr. Metcalfe practices in London, Birmingham and Southampton in the United Kingdom, including the Phoenix Hospital Group facilites at the Weymouth Street Hospital and 9 Harley Street. These facilities are centrally located in London offering high quality facilities and advanced surgical and patient care. With his expertise and quality care, Mr. Metcalfe meets and exceeds the qualitfications to be certified as a HyProCure ICOE. The HyProCure ICOE program recognizes expert physicians, medical groups, and health care centers accomplished at performing Extra-Osseous TaloTarsal Stabilization (EOTTS) procedures with HyProCure and providing consummate post-operative care. For more information about Mr. Metcalfe and the services he provides, visit http://www.footconsultant.com.

GraMedica's ICOE is a global program to reach out to a large patient population suffering from foot and ankle disorders and is designed to increase the awareness and medical services provided by experts in foot and ankle care. Left untreated, talotarsal joint misalignment can lead to serious, long-term foot, knee, hip, and back related issues that often require aggressive forms of surgery. The minimally invasive EOTTS with HyProCure® procedure has provided tens of thousands of pediatric and adult patients with immediate correction for congenital/acquired talotarsal joint misalignment. For more information about talotarsal joint dislocation and more information about HyProCure, visit http://www.HyProCure.com.

About GraMedica

GraMedica is a global orthopedic medical device company passionate about creating innovative foot and ankle products that improve patient options and outcomes. Together with our sister organization, the Graham International Implant Institute (GIII), we educate foot and ankle surgeons in over 50 countries. We are committed to helping create ongoing improvement in the quality of healthcare for both patients and physicians through premier product lines including HyProCure® and osteo-WEDGE™. To learn more about GraMedica, please visit our website at www.gramedica.com. Physicians can learn more about Graham International Implant Institute at http://www.grahamiii.com.